Beijing Strong Biotechnologies, Inc.
SHZ: 300406.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Hongjun Liang
- Employees
- 1,094
- Headquarters
- Beijing, China
- IPO year
- 2014
- Market cap
- CN¥7.7B
- Website
- https://www.bsbe.com.cn
Loading 300406…
Loading profile data…Frequently asked questions about 300406
What does Beijing Strong Biotechnologies, Inc. (300406.SZ) do?
Beijing Strong Biotechnologies, Inc. provides in-vitro diagnostics products and services in the People's Republic of China and internationally. It offers clinical biochemistry products, such as reagents and automatic biochemistry analyzers; coagulation products, including reagents and automated coagulation analyzers; and serology products compri...
Where does 300406.SZ trade?
Beijing Strong Biotechnologies, Inc. (300406.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300406.SZ in?
Beijing Strong Biotechnologies, Inc. (300406.SZ) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Beijing Strong Biotechnologies, Inc.?
Hongjun Liang is the chief executive officer of Beijing Strong Biotechnologies, Inc. (300406.SZ).
Where is Beijing Strong Biotechnologies, Inc. headquartered?
Beijing Strong Biotechnologies, Inc. is headquartered in China.
Does 300406.SZ pay a dividend?
Yes — Beijing Strong Biotechnologies, Inc. (300406.SZ) paid a trailing twelve-month dividend of CNY 0.90 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300406.SZ go public?
Beijing Strong Biotechnologies, Inc. (300406.SZ) completed its initial public offering in 2014.